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ABSTRACT 
Common photosensitizers used in photodynamic therapy do not penetrate the skin effectively.  In 
addition, the visible blue and red lights used to excite such photosensitizers have shallow 
penetration depths through tissue. To overcome these limitations, we have synthesized ultraviolet 
and visible light emitting, energy-transfer based upconversion nanoparticles, and co-encapsulated 
them inside PLGA-PEG nanoparticles with photosensitizer protoporphyrin IX. Nd3+ has been 
introduced as sensitizer in the upconversion nanostructures to allow their excitation at 808 nm. 
The subcytotoxic doses of the hybrid nanoparticles have been evaluated on different cell lines 
(i.e., fibroblasts, HaCaT, THP-1 monocytic cell line, U251MG, and mMSCs cells). Upon NIR 
light excitation the upconversion nanoparticles emitted UV and VIS light which consequently 
activated the generation of reactive oxygen species (ROS). In addition, after irradiating at 808 nm, 
the resulting hybrid nanoparticles containing both upconversion nanoparticles and protoporphyrin 
IX generated 3.4 times more ROS than PLGA-PEG nanoparticles containing just the same dose of 
protoporphyrin IX. Their photodynamic effect was also assayed on different cell cultures 
demonstrating their efficacy to selectively kill treated and irradiated cells. Compared to the topical 
application of the free photosensitizer, an enhanced skin permeation penetration was observed for 
the nanoparticulate formulation using an ex vivo human skin permeation experiment. Whereas 
free protoporphyrin IX remained located at the outer layer of the skin, nanoparticle-encapsulated 









During the last decades, luminescent upconversion nanoparticles have been the focus of 
extensive research in the optoelectronics and biomedical fields due to their ability to convert near 
infrared (NIR) light to shorter wavelength light (VIS or UV), a process termed upconversion. The 
upconversion properties of these luminescence nanoparticles are attractive because in biomedical 
applications, NIR excitation is commonly used to maximize tissue penetration, minimize 
background autofluorescence and reduce photobleaching. However, UV or VIS light activates 
most of the photo-triggerable processes.  
The UV and VIS light emitted by the upconversion nanoparticles together with the intrinsic 
characteristics of some activators (i.e., paramagnetic Gd3+) have promoted the use of 
upconversion nanoparticles in various biomedical applications including fluorescence and 
magnetic resonance imaging, drug delivery, biosensing, and photodynamic therapy1. 
Photodynamic therapy using upconversion nanoparticles has been applied in vitro and in vivo in 
the treatment of tumors by using the VIS light generated by the nanoparticles in the activation of a 
photosensitizer located in close proximity to the upconversion nanoparticle which generates short-
lived reactive oxygen species that eliminate cancer cells2.  
Drug and gene delivery systems have also been developed using the un-caging ability of the UV 
light generated by upconversion nanoparticles after NIR excitation. In this regard, Yan et al.3 
synthesized UV-responsive block copolymer micelles co-containing both upconversion 
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nanoparticles and dyes (i.e., Nile red). The NIR light excitation induced the generation of UV 
light by the caged upconverting nanoparticles, which consequently produced the photocleavage of 
specific labile groups of the micelle-forming block copolymer releasing the dye used as model 
payload. Photocaging of reporter and silencing genes has been demonstrated even in vivo using 
NIR-to-UV upconverting nanoparticles showing that it is feasible to obtain site-specific gene 
knockdown and patterning of biomolecules using externally applied NIR light4,5. Liu et al.6 
demonstrated the NIR-triggered anticancer drug release based on the use of upconverting 
nanoparticles coated with a mesoporous silica shell containing the drug and using the trans–cis 
photoisomerization of azobenzene molecules as molecular gates. In this case, upon NIR light 
illumination the UV light generated by the upconverting crystal triggered the photoisomerization 
and consequent drug release. Multifunctional platforms have also been reported combining the 
ability of the NIR-to-UV upconversion nanoparticles to simultaneously trigger drug release and 
also monitor the presence of the nanoparticles in the tissues7,8. In addition, multimodal bioimaging 
using computed tomography, upconversion luminescence and magnetic resonance imaging 
together with photodynamic effects have been demonstrated using mesoporous silica coated 
upconversion nanoparticles containing two different photosensitizers9. 
The localization of the drug on the affected area, its reduced side effects, and non-invasive 
character make topical drug administration advantageous over other administration routes. In 
photodynamic therapy, the topical delivery of organic photosensitizers is limited by their intrinsic 
photobleaching together with their low permeance through the epidermis. To facilitate the 
permeation through the intracellular lipids (i.e., neutral lipids and sphingolipids) of the stratum 
corneum, the photosensitizer carrier should have a pH similar to that of the skin (i.e., 5.5) and 
intrinsic hydrophobicity to avoid agglomeration. Nanoparticulate systems encapsulating both 
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hydrophilic and hydrophobic photosensitizers can overcome those limitations to favor the 
accumulation of the dye into the dermis. In photodynamic therapy blue and red light are 
commonly used to generate reactive oxygen species (ROS); however these VIS wavelengths show 
shallow penetration depths10 whereas NIR light shows higher penetration into the tissues11. In 
order to overcome the limited topical penetration of photosensitizers and the reduced penetration 
depth of the VIS light commonly used in photodynamic therapy, herein, energy transfer-based 
upconversion nanoparticles based on Yb3+ as sensitizer and varied activators (i.e., Tm3+, Er3+, 
Gd3+, etc.) emitting VIS and UV light after being excited with NIR light have been prepared. 
Those nanoparticles have been co-encapsulated inside PLGA-PEG nanoparticles containing also 
the endogenous photosensitizer protoporphyrin IX, commonly used in actinic keratosis and skin 
cancers. ROS generation after NIR light irradiation at 808 nm using an ex vivo skin permeation 
experiment has been successfully demonstrated. Hence, the current limitations of photodynamic 
therapy that include the reduced penetration of hydrophilic photosensitizers (e.g., 5-
aminolevulinic acid), their quick photobleaching, and also the shallow penetration depth of the 
visible light commonly applied during treatment can be overcome by encapsulating hydrophobic 
forms of the photosensitizer (i.e., protoporphyrin IX) combined with upconversion nanoparticles 
which allow using highly penetrant NIR light to trigger the generation of reactive oxygen species. 
Therefore, we demonstrate that using upconversion nanoparticles it is possible to employ 
externally applied NIR light to generate UV or VIS light underneath the skin and trigger the 
activation of a photosensitizer in close proximity to the upconverting nanoparticles with the 
consequent ROS generation. In addition, enhanced photosensitizer skin permeation was reached 




RESULTS AND DISCUSSION 
Synthesis of PLGA-PEG nanoparticles co-containing upconversion nanoparticles and 
protoporphyrin IX. Figure 1 shows the morphology of the upconverting crystals resulting from 
the solvothermal synthesis. TEM photographs show the NaYF4:Yb3+ crystals with a characteristic 
thermodynamically stable hexagonal structure (β phase), which was corroborated by high-
resolution scanning transmission electron microscopy (STEM) and by XRD analysis (Figure S1a). 
By tilting the TEM holder we observed a hexagonal flat plate structure characteristic of a 
NaF/Yb3+ molar ratio of 8 in agreement with the previous literature12. Particle sizes of 41.1±2.3 
nm were measured from the TEM images (N=250). Core and shell are not distinguishable by 
TEM because of their close crystalline structures and compositions as previously reported13, but 
shell size could be determined by subtracting the total size from the core mean diameter (Figure 
1a), showing a mean thickness of 22.3±2.6 nm. Oleic acid, chemisorbed onto the surface of the 
upconversion nanoparticles via its carboxylate group, acts as solvent and stabilizer preventing the 
resulting nanoparticles from agglomeration in organic solvents14. During TEM observation, long-
range ordered structures were observed after drying the particles, corroborating the presence of 
the oleic acid on the nanoparticle surfaces. EDX analysis (Figure S1b) confirmed the presence of 
the elements of the host matrix (i.e., NaYF4), the sensitizer (Yb3+), the activator and accumulator 
(Tm3+) and also Nd3+ (to promote energy transfer to the activator, i.e., Yb3+, and the consequent 








Figure 1. (a) TEM images of the core (left) composed of β-NaYF4: Gd, Yb, Nd, Tm and the final 
core-shell nanoparticles (right) composed of β-NaYF4: Gd, Yb, Nd, Tm/NaYF4:Nd and (b) 
HRTEM images of a single core-shell nanocrystal; (c) Side view of one core-shell nanocrystal 
from different tilt angles revealing the hexagonal nanoplate structure. 
Gd3+ was also incorporated and detected in the nanoparticle core to achieve UV emission and to 
enhance upconversion luminescence thanks to its fast energy migration and because its excited 
and ground states are separated by a relatively large energy gap which reduces energy losses by 
multiphonon emission and cross-relaxation13. In addition, excited Gd3+ states showed high order 
upconversion emissions in the UV region (i.e., 311.7 nm) due to the 6P7/2-8S7/2 transitions15. The 
emissions generated by the nanoparticles after excitation at 980 and 808 nm are depicted in Figure 
2, as well as their corresponding energy transfers (Figure S1c). These nanoparticles showed a 3- 
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and 4-order of the upconversion process after calculating the slope of the luminescence intensity 
versus different pump powers in double-logarithmic representation16 (Figure S2). This means that 
for those core-shell nanoparticles the emissions in the VIS and UV regions of the electromagnetic 
spectrum are 3- and 4-photon processes, respectively17,18. This indicates that to up to 4 photons are 
absorbed simultaneously by the sensitizer and one of its electrons promoted from a lower energy 
level to a higher one. In this case, Yb3+ acts as sensitizer because it shows of all lanthanide ions 
the largest absorption cross section at 980 nm (near infrared wavelength usually employed to 
excite those materials) due to 2F7/2-2F5/2 transitions, acting other lanthanides as activators of the 
upconversion emission thanks to the resonant character of their f-f transitions with the Yb3+ 
transitions19. Nd3+ was also introduced as sensitizer in the resulting core-shell upconversion 
nanostructures to allow their excitation at 808 nm (common wavelength used in photothermal 
therapy) and simultaneous energy transfer to Yb3+ thanks to the multiple excitation bands that 
Nd3+ shows at 730, 808, and 865 nm, corresponding to transitions from 4I9/2 to 4F7/2, 4F5/2, and 
4F3/2, respectively20. 
Figure 2a shows the optical emission of the upconverting crystals in ethanol where the 
predominant blue emission (at 450-480nm) is clearly observable when irradiated with 980 and 
808 nm wavelength lasers. In addition, this emission was preserved in water after nanoparticle 
surface functionalization with polyethylenglycol thiol (SH-PEG). The absorption spectrum of the 
nanoparticles (Figure 2b) showed absorbance at 808 and 980 nm and large scattering at short 
wavelengths but reduced scattering in the NIR region, which represents the possibility of 






Figure 2. (a) Normalized emission spectra under 
excitation at 980 nm (top) and 808 nm (bottom) 
and their respective luminescence photographs of 
vials with the nanoparticle dispersions. The spectra 
and photographs were recorded in ethanol (1 
mg/mL) using a power of 350 W/cm2. (b) UV-Vis 
absorbance spectrum of the resulting core-shell 
nanoparticles composed of β-NaYF4: Gd, Yb, Nd, 
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Tm/NaYF4:Nd. (c) luminescence photograph of 
PEG functionalized core-shell nanoparticles (1 
mg/mL) dispersed in water and contained in a vial. 
As described in the Materials and Methods section, PLGA-PEG nanoparticles containing 
upconversion nanoparticles were prepared by nanoprecipitation using miscible solvents (water 
and tetrahydrofuran, THF). Aqueous dispersions (10 mg/mL) of PLGA-PEG nanoparticles 
containing upconversion nanoparticles (28.6 ± 0.8 wt.%, measured by thermogravimetric analysis, 
TGA) did not produce blue emission visible to the naked eye after NIR (808nm) irradiation (530 
W/cm2); however their resulting freeze-dried powders did (Figure S3). Hence, the upconversion 
emission remained inside the PLGA-PEG nanoparticles after encapsulating the upconversion 
nanoparticles. In addition to the light scattering caused by the PLGA-PEG nanoparticles, water 
quenches upconversion emission due to the energy transfer between the upconverting crystal and 
the water molecules and because of the excitation energy depletion that water produces due to its 
inherent absorption (although reduced) in the NIR region21. Those reasons might explain why the 
emission was not observable to the naked eye when using the colloidal water-based suspension 
but it was clearly observed when using its resulting freeze-dried powders. With the same 
upconversion-nanoparticle loading (28.6 ± 0.8 wt.%) inside PLGA-PEG, lyophilized powders of 
PLGA-PEG nanoparticles containing both protoporphyrin IX and upconversion nanoparticles did 
not show any emission under the same irradiation conditions which could be attributed to the light 
absorption caused by the protoporphyrin IX (Figure S2). This is not surprising considering that 
light emission is generated in close proximity to the production site. Hence, after irradiating at 808 
nm (530 W/cm2) the upconversion emission of the inner lanthanide-based crystals was absorbed 
by the closely packed porphyrin. This dye shows a maximum absorption in the blue (440-480nm) 
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and red (650-800nm) regions of the electromagnetic spectrum22, which overlaps with the emission 
of the upconversion crystals (maximum at 477, 451 and 647-661nm, Figure S1c). 
PLGA-PEG nanoparticles containing both protoporphyrin IX and upconversion nanoparticles 
are depicted in Figure 3. The particle size of the final hybrid nanoparticles was 288.1 ± 49.2 nm 
measured by TEM (N=50). Encapsulation efficiencies of 6.24 ± 0.8 wt. % (ratio between the 
measured protoporphyrin IX mass and the mass of protoporphyrin added in the synthesis) and 
drug loadings of 0.22 ± 0.03 wt. % (ratio between the measured protoporphyrin IX mass and the 
mass of PLGA-PEG, calculated by TGA) were calculated by fluorescence spectroscopy 





Figure 3. (a) TEM images of PLGA-PEG 
nanoparticles obtained by nanoprecipitation. (b) 
TEM and (c) STEM-HAADF images of PLGA-
PEG NPs containing both core-shell UCNPs 
(28.6 ± 0.8 wt.%) and protoporphyrin IX (0.22 ± 
0.03 wt.%). 
The inner upconversion crystals were clearly visualized under TEM due to their high electron 
density. The size of the final hybrid nanoparticles is still lower than the maximum sizes (< 200-
300 nm) reported for the topical delivery of protoporphyrin IX (or 5-aminolevulinic acid, which is 
the protoporphyrin IX endogenous precursor in the porphyrin synthesis pathway). Reduced 
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nanoparticle sizes would favor the topical delivery of the porphyrin through the lipid stacks 
located between the proteinaceous dead cells (i.e., corneocytes) of the stratum corneum. 
Free radical generation by the hybrid nanoparticles. ROS generation after 980nm-light 
irradiation was evaluated by collecting the emission of R123 (rhodamine 123) at 530 nm in the 
presence of the non-encapsulated upconversion nanoparticles. The heating rate upon the laser 
irradiation on upconversion nanoparticles under the presence of DHR123 (Dihydrorhodamine 
123) was evaluated in order to decouple the photothermal effect from the photochemical effect 
that was exerted on the dye. Figure 4a shows that the colloidal nanoparticle suspension (5 mg/mL) 
reached 50ºC (∆T=26ºC) in 8 min upon laser irradiation (11 W/cm2; such high irradiance was 
used to obtain a fast response). Under the same irradiation conditions an ethanolic solution of 
DHR123 without the nanoparticles showed a temperature increase of ∆T=13ºC. Heating at 50ºC 
by applying the laser or having the presence of upconverting nanocrystals (5 mg/mL) did not 
induce DHR123 degradation, showing the same fluorescence intensity irrespectively of the 
exposure time (Figure S4) in agreement with the previous literature24; however, the presence of 
nanoparticles and heating simultaneously promoted DHR123 oxidation (Figure 4b). This 
phenomenon could be partially explained by the generation of reactive nitrogen species after 
heating water under the presence of DHR123, as previously reported25. This reaction could be 
potentially catalyzed by the presence of the lanthanide nanocrystals. Upconversion nanoparticles 
irradiation at 980 nm induced free radical generation 1.2 times greater than the heating of the 
nanoparticles alone did. This is indicative of the ROS generation by the upconverting crystals 
probably caused by the UV and VIS light they produce as previously reported2. The irradiation of 
the DHR123 dissolved in ethanol without nanoparticles did not induce ROS generation (Figure 
S4, top right). Hence, the upconversion nanoparticles themselves were able to produce ROS after 
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NIR light irradiation and these free radicals could potentially be used to cause photo-oxidation of 
malignant cells. 




































Figure 4. (a) Heating rate under laser irradiation 
(980 nm, 11 W/cm2) of a colloidal suspension in 
ethanol (1 mL) of the upconversion nanoparticles 
(5 mg/mL) and (b) DHR123 fluorescence emission 
at 530 nm after irradiation and heating at different 
times in a colloidal suspension (5 mg/mL) of 
UCNPs (three independent replicas). 
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Determination of the sub-cytotoxic dose of the hybrid nanoparticles and in vitro 
photodynamic effects. In vitro cytotoxicity of the synthesized nanoparticles was measured 
against different cell lines (Figure 5). Oleic-acid capped (Figure 5a) and SH-PEG functionalized 
(Figure 5c) upconversion nanoparticles did not display cytotoxic effects up to 0.4 mg/mL on the 
five cell lines assayed showing viabilities above 70%. The interference of the nanoparticles at the 
highest concentration with the assay was evaluated and discarded. Even much higher doses of 
similar upconversion nanoparticles have shown no toxic effect on different animal models26. 
PLGA-PEG nanoparticles containing upconversion nanoparticles only or containing both 
protoporphyrin IX and upconversion nanoparticles were also found to be noncytotoxic27 at the 
concentrations tested (0.01-0.4 mg/mL) on fibroblasts and keratinocytes. A similar finding was 
demonstrated with the unloaded PLGA-PEG NPs. On the other hand, macrophage viability 
slightly decreased (p < 0.005) below 70% cell viability after treatment with PLGA-PEG 
nanoparticles containing upconversion nanoparticles. The macrophage viability also decreased 
after treatment with PLGA-PEG nanoparticles containing both upconversion nanoparticles and 
protoporphyrin IX compared to the control (untreated) samples (Figure 5d), which may be 
attributed to the phagocytic role of this cell line28 so their NP uptake may be higher compared to 
the other cells assayed. However, the morphology of macrophages remained unaltered after being 
in contact with the oleic-acid capped nanoparticles (0.01 and 0.4 mg/mL) for 24 h, which could be 
another indication of the cytocompatibility of the upconversion nanoparticles at the doses tested 
(Figure 5b). We chose macrophages for SEM observation because of the elevated nanoparticle 
phagocytic uptake of this cell line. The cell survival exerted by the upconversion nanoparticles 
above 60-70% was attributed to their low water solubility and consequent reduced cellular contact 
of the oleic acid-caped nanoparticles in one case and to the buffering effect that PEG produces on 
 
15 





















































































































































































Figure 5. Viability assay using five cellular lines of (a) oleic-acid capped and (c) SH-PEG 
functionalized upconversion nanoparticles. (b) SEM images of macrophages incubated for 24h 
with oleic-acid capped upconversion nanoparticles at 0.01 mg/mL (top-right) and 0.04 mg/mL 
(bottom-left), SH-PEG functionalized upconversion nanoparticles at 0.01 mg/mL (bottom-right) 
and control (top-left) (d) Viability comparison between PLGA-PEG NPs, upconversion 
nanoparticles encapsulated in PLGA-PEG and PLGA-PEG NPs containing upconversion 
nanoparticles and Protoporphyrin IX, using three different cell lines. Control samples (not 
treated cells) were set as reference of viability (100%). N=5.  
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Several studies have shown the low toxicity of upconversion nanoparticles mainly against 
tumoral cells and macrophages26, though, to the best of our knowledge, their toxicity against 
fibroblasts and keratinocytes has not been shown before. The treatment of human gastric cancer 
cells with lanthanide nanoparticles for the photodynamic treatment of tumors did not display high 
cytotoxicity except for the highest concentration assayed (1 mg/mL) of a mixture composed of 
protoporphyrin IX and lanthanide nanoparticles. However, this cytotoxicity was only observed 
after NIR irradiation, and it was attributed to the singlet oxygen generation and the subsequent 
photodynamic cellular damage29. In this regard, the addition of upconversion nanoparticles 
functionalized with α-cyclodextrin to A-549 cells resulted in high viability at values up to 0.4 
mg/mL, showing again their high ability to produce cytotoxic singlet oxygen after NIR 
irradiation30. The cytotoxic effects of PEGylated upconversion nanoparticles were assessed 
against human liver cells and murine macrophages as nanoparticles are prone to be accumulated 
in the liver and spleen after IV administration, exerting high viability percentages (>82%) at 
concentrations between 0.05 and 1.6 mg/mL31.  
Photodynamic effects derived from ROS generation on different cell types, such as melanoma 
cells (B16F1), mouse mesenchymal stem cells (mMSCs), human dermal fibroblasts and human 
macrophages, were also tested (Fig. 6, Fig. S5 and Fig S6) by fluorescence microscopy after 
staining live cells with calcein and dead cells with ethidium bromide. After 20 minutes irradiation 
on melanoma cells treated with PLGA-PEG NPs containing upconversion NPs and 
protoporphyrin, oxidative damage was immediately detected in the irradiated area (Fig 6a) 
showing a central area of dead cells (red) corresponding with the laser spot surrounded by live 
cells (green). The temperature of the culture was monitored and no temperature increase was 
observed, discarding any thermal mediated cell damage. Samples irradiated at shorter times (5 and 
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10 min) needed 24h to clearly exert oxidative cell damage (Fig 6b and 6c), underlining the 
dependency on the irradiation time to obtain an accentuated cellular damage by biomolecule 
photooxidation32. It should be noted that after 24h, samples irradiated for 20 minutes did not 
contain cells, suggesting an extensive cell death and detachment. Furthermore, control samples, 
both treated and/or irradiated with the separated components of the final NPs (PLGA-PEG NPs, 
upconversion NPs and protoporphyrin IX), did not exert oxidative damage (Fig S5), and the 
increase in the temperature of the cell wells was always < 2 ºC (data not shown), pointing to the 
restricted photodynamic effect of the final nanomaterials mediated by ROS. The other cell types 
assayed also displayed cell death mediated by ROS after 24h when treated with PLGA-PEG NPs 
containing upconversion nanoparticles and Protoporphyrin IX after irradiation, being more 
accentuated in the phagocytic cell type (macrophages) than in mesenchymal and fibroblast cells 
(Fig S6). Different nanoparticles are commonly used to generate photodynamic effects33,34; but 
these results highlight the photodynamic effect of our NPs showing high viability when cells were 
not irradiated though displaying an extensive oxidative cell damage and subsequent death after 
NIR irradiation. In this line, previous works have shown the effects of photodynamic therapy 
mediated by NIR irradiation on tumor cells treated with the photosensitizer protoporphyrin 
mediated by its precursor 5-aminolevulinic acid (ALA). A431 squamous carcinoma cell 
monolayers and 3D cultures were treated with ALA in order to obtain PPIX, and subsequently 
irradiated (LED light at 15 mW)35. The evaluation of the samples 24h after irradiation showed a 
central spot of dead cells consistent with our studies. Cell viability of different tumor cells (i.e., 
AtT-20 and U373) treated with ALA also showed a decrease 12-14h after irradiation though this 
treatment on GH3 cells, which present an additional mechanism for protoporphyrin efflux, did not 
exert changes in cell viability36. Also, the efficient photodynamic effects of ALA treatment to 
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obtain PPIX on dormant PC-3 prostate cancer spheroids, which accumulate high levels of PPIX, 
were clearly demonstrated through the high cell mortality displayed 24h after irradiation37. 
 
 
Figure 6. Photodynamic effects on murine melanoma cells (B16F1 cell line). Composition of 
pictures (4X magnification) obtained by fluorescence microscopy to show the whole culture well 
when cells were treated for 24h with PLGA-PEG NPs containing upconversion nanoparticles and 
Protoporphyrin IX. (a) B16F1 cells laser irradiated (808 nm) for 20 min and images acquired 
immediately after irradiation; (b and c) B16F1 cells laser irradiated for 5 min (b) and 10 min (c) 
and images acquired 24h after irradiation. Live cells are stained in green while dead cells in red. 
Thus, the biomedical potential of upconversion nanoparticles lies in producing no cytotoxicity 
without light activation, but this can be triggered by means of NIR irradiation and consequent 
singlet oxygen production displaying their photodynamic therapeutic effects. 
Ex vivo skin permeation experiment. Singlet oxygen generation using the singlet oxygen 
sensor green revealed that after irradiating at 808nm (800 mW/cm2) the PLGA-PEG nanoparticles 
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containing both upconversion nanoparticles and protoporphyrin IX generated 3.4 times more 
singlet oxygen than PLGA-PEG nanoparticles containing just the same dose of protoporphyrin IX 
(Figure S7). These results suggest that the co-encapsulation of UCNP effectively excited 
protoporphyrin IX and enhanced the generation of singlet oxygen from protoporphyrin IX-loaded 
particles. PLGA-PEG nanoparticles containing upconversion nanoparticles without 
protoporphyrin IX did not generate ROS at concentrations above the detection limit of the 
fluorometer, showing that the observed enhancement of singlet oxygen generation in Figure S7 
was not due to the ROS generation from the UCNP itself. Again, due to the short half-life of ROS, 
they are only effective when located very close to the production site38 and accordingly we 
demonstrated that the activation of the upconversion nanoparticles generates enough emitted light 




Figure 7. Confocal laser scanning microscopy images of the skin penetration test. 
 
The PPIX-loaded nanoparticles were placed onto human skin and the skin penetration properties 
of these nanoparticles were studied using a Franz Diffusion Cell. The skin permeation test 
revealed that whereas free protoporphyrin IX was unable to permeate through the skin after 24 h 
at room temperature, once encapsulated within the PLGA-PEG polymeric nanoparticles the dye 
was able to permeate the epidermis layer and reach into the dermis (Figure 7). The reduced skin 
permeability of free protoporphyrin IX could be attributed to its aggregation at the pH of the 
skin39, which can be improved by using penetration enhancers, by chemical modification or  by 
encapsulation as here reported. These results demonstrate that the nanoparticulate form of 




Core-shell upconversion nanoparticles are able to induce ROS generation upon 808nm-NIR 
light irradiation. Co-encapsulation of upconversion nanoparticles and photosensitizers inside 
PLGA-PEG nanoparticles allows transdermal delivery and an enhanced ROS generation (3.4 
times greater) compared to that achieved with just the encapsulated photosensitizer. The 
photodynamic effect of those nanoparticles was also demonstrated in vitro producing ROS 
mediated damage in cells. By confocal laser scanning microscopy we have demonstrated that free 
lipophilic protoporphyrin IX remains mainly on the top skin layer but the PLGA-PEG 




MATERIALS AND METHODS 
PLGA-PEG Resomer® RGP d5055 was purchased from Evonik Industries AG (Germany). 
Protoporphyrin IX (95%), Yttrium (III) chloride hexahydrate (99.99%), Neodymium (III) chloride 
(99.9%), Thulium (III) chloride (99.9%, Gadolinium (III) chloride hexahydrate (99.99%), 
Ytterbium (III) chloride hexahydrate (99.998%), Oleic acid (90%), 1-octadecene (90%), 
Ammonium Fluoride (98%), sodium hydroxide (98%) and dihydrorhodamine 123 (95%) were all 
purchased from Sigma-Aldrich and used as received. All other chemicals were also purchased 
from Sigma-Aldrich unless otherwise noted. 
Synthesis of β-NaYF4: Gd, Yb, Nd, Tm cores. 8 mL of a 0.2M aqueous solution of YCl3, 
GdCl3, YbCl3, NdCl3 and TmCl3 (lanthanide ion molar ratio: Y/Gd/Yb/Nd/Tm = 58.5:20:20:1:0.5) 
was mixed with 24 mL of 1-octadecene and 16 mL of oleic acid in a 250 mL three-neck round 
bottom flask. The mixture was heated slowly (3 ºC/min) under stirring to 170 ºC to remove water 
and to produce oleate complexes, and then cooled down to room temperature. 4 mL of a sodium 
hydroxide solution in methanol (1M) was mixed with 13.2 mL of an ammonium fluoride solution 
in methanol (0.4M) and immediately added to the cooled reaction. The flask was stirred at room 
temperature for 40 minutes and then heated to 100 ºC (15 ºC/min) under vacuum to completely 
remove the methanol. Finally, the reaction was heated to 305 ºC (15 ºC/min), maintained at this 
temperature for 90 minutes and cooled to room temperature. The synthesis was protected from 
oxidation by a constant flow of dry argon throughout the process. Core nanoparticles were then 
collected from the reaction flask by centrifugation (6000 rpm/10 min) after adding 60 mL of 
ethanol and finally dispersed in 16 mL of cyclohexane. 
Synthesis of β-NaYF4: Gd, Yb, Nd, Tm / NaYF4: Nd core-shell structures. 8 mL of a 0.2M 
aqueous solution of YCl3, NdCl3 (lanthanide ion molar ratio: Y/Nd = 8:2) was mixed with 24 mL 
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of 1-octadecene and 16 mL of oleic acid in a 250 mL three-neck round bottom flask. The mixture 
was heated slowly under stirring to 170 ºC (3 ºC/min) to remove water and to produce oleate 
complexes, and then cooled down to room temperature. 
The previously synthesized core nanoparticles were transferred to the reaction flask and stirred 
for 5 minutes. Then, 4 mL of a sodium hydroxide solution in methanol (1M) was mixed with 13.2 
mL of an ammonium fluoride solution in methanol (0.4M) and added immediately. The flask was 
stirred at room temperature for 40 minutes and then heated to 100 ºC (15 ºC/min) under vacuum to 
completely remove the methanol and cyclohexane. Finally, the reaction was heated to 305 ºC (15 
ºC/min) maintained at this temperature for 90 minutes and cooled down to room temperature. The 
synthesis was also protected from oxidation by a constant flow of dry argon throughout the 
process. The final product was collected from the reaction by centrifugation (6000 rpm/10 min) 
after addition of 60 mL of ethanol, purified by two cycles of centrifugal washing in cyclohexane 
(12000 rpm/20 min) and dried under vacuum. 
The resulting nanoparticles were ligand-exchanged with polyethylene glycol thiol to render 
them water-soluble. Different strategies have been followed to carry out this direct exchange 
including click chemistry40, In our case, we removed the oleic acid coating according to the 
following protocol: the oleic-acid capped nanoparticles were first re-dispersed in HCl aqueous 
solution (0.1 M) at a concentration of 10 mg/mL and sonicated for 20 minutes to detach the oleic 
acid by repeating this procedure 3 times. The uncapped nanoparticles were dried under vacuum 
and dispersed in water at a final concentration of 2 mg/mL and reacted with polyethylene glycol 
methyl ether thiol (SH-PEG, 800 Da, 2mg/mL) in a volume ratio of 1:1, and stirred for one hour. 
Finally, PEGylated upconversion nanoparticles were washed by several centrifugation cycles in 
water (10000 rpm/20 min) to remove unbound SH-PEG. Thiol forms a dative bond with metal 
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atoms due to the lone pair of electrons on the sulfur atom and the PEG corona provides the 
nanoparticles with steric hindrance and increases the hydrophilicity via ether repeat units, which 
form hydrogen bonds with water41.  
Upconversion nanoparticles and protoporphyrin IX encapsulation in PLGA-PEG. 
Upconversion nanoparticles and protoporphyrin IX were co-encapsulated in PLGA-PEG using a 
nanoprecipitation method. Briefly, 5 mg of PLGA-PEG, 5 mg of core-shell upconversion 
nanoparticles and 250 µg of protoporphyrin IX were dissolved in 1 mL of tetrahydrofuran (THF). 
This dispersion was added drop-wise at 2 mL/h using a syringe pump (model PHD Ultra, Harvard 
Apparatus, Holliston, MA, USA) over 1 mL of milli-Q water magnetically stirred (380 rpm). 
Then, THF was evaporated by magnetic stirring at room temperature for 2 hours and nanoparticles 
were purified to remove leftover THF and non-encapsulated protoporphyrin IX by four cycles of 
centrifugal washing in milli-Q water (6000 rpm/10 min). 
Nanoparticle characterization. Optical characterization measurements were performed using 
an optical setup consisting of a quartz cell (High precision Suprasil® quartz cell, Hellma GmbH 
and Co. KG, Mullheim, Germany) with two coplanar optical fibers placed at 90º in two 
perpendicular faces of the cell. One optical fiber (model SMA905 – 400 µm in diameter, Ocean 
Optics, Dunedin, FL, USA) was attached to a 980nm-laser diode (model MDL-III-980-2W, 
Changchun New Industries Optoelectronics Technology Co., Ltd., Changchun, P.R. China) 
connected to a laser power supply (model PSU-III-LED). The other optical fiber (P600-025-UV-
VIS - 600 µm in diameter, Ocean Optics, Dunedin, FL, USA) was attached to a modular 
spectrometer calibrated in the UV-VIS region (model Black-Comet, StellarNet Inc. Tampa, FL, 
USA). The same experimental set up was used to evaluate the nanoparticles emission at 808nm 
but in this case using a 808nm-laser diode (model MDL-III-808-2W, Changchun New Industries 
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Optoelectronics Technology Co., Ltd., Changchun, P.R. China). All samples were measured in 
ethanol at a concentration of 1 mg/mL and using a laser irradiance of 350 W/cm2. The 
upconversion nanoparticle loading within PLGA-PEG nanoparticles was determined by 
thermogravimetric analysis (TGA, model Q5000IR, TA Instruments, New Castle, DE, USA) 
using a 10 ºC/min heating rate under a nitrogen atmosphere. 
Subcytotoxic dose determination and photodynamic in vitro effects mediated by ROS. 
Human dermal fibroblasts (Lonza, Belgium), B16F1 mouse melanoma cells (kindly donated by 
Dr Pilar Martin-Duque), HaCaT human keratinocytes (Lonza, Belgium) and U251MG 
Glioblastoma (Cancer Research-UK) cell lines were grown using Dulbecco’s modified Eagle’s 
medium high glucose (DMEM w/stable Glutamine, Biowest) supplemented with fetal bovine 
serum (FBS, 10% (v/v); Thermo Fisher Scientific) and antibiotic-antimycotic (60 µg/mL 
penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin B, Biowest) in a humidified 
atmosphere containing 5% CO2 at 37ºC.  THP-1 cell line (human acute monocytic leukemia 
suspension cell) was purchased from American type Culture Collection (ATCC, TIB-202™; 
Manassas, VA) and cultured in RPMI 1640 medium (Gibco, Thermo Fisher Scientific) 
supplemented with fetal bovine serum (FBS, 10% (v/v); Thermo Fisher Scientific), non-essential 
aminoacids (1%; Biowest), sodium piruvate (1 mM; Biowest), HEPES (10 mM; Biowest 2-
mercaptoethanol (0.05 mM, Gibco, Thermo Fisher Scientific), stable glutamine (2 mM; Biowest)  
and antibiotic-antimycotic (60 µg/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL 
amphotericin B, Biowest) at 37 °C in a 5% CO2 humidified incubator. Monocytic cells were 
differentiated into the adherent macrophage-like state in supplemented RPMI 1640 medium 
containing 1 µM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich) for 72 h.  
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Mouse mesenchymal stem cells (mMSCs) (Lonza, Belgium) were cultured in Dulbecco’s 
modified Eagle’s F-12 medium (DMEM F-12, Biowest) supplemented with fetal bovine serum 
(FBS, 10% (v/v); Thermo Fisher Scientific), stable glutamine (2 mM; Biowest) and antibiotic-
antimycotic (60 µg/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin B, 
Biowest) and maintained at 37°C in a 5% CO2-humidified atmosphere under hypoxic conditions 
(3% O2). 
In vitro cytotoxicity of oleic-acid capped and SH-PEG functionalized upconversion 
nanoparticles as well as unloaded PLGA-PEG nanoparticles and upconversion nanoparticles 
encapsulated in PLGA-PEG and PLGA-PEG nanoparticles containing upconversion nanoparticles 
and protoporphyrin IX were evaluated using the Alamar Blue assay (Invitrogen) according to the 
manufacturer’s instructions. B16F1, HaCaT, THP-1 monocytic cell line, U251MG, fibroblasts, 
and mMSCs cells (density of 5000, 5000, 30000, 5000, 6000 and 5000 cells/well, respectively) 
were seeded in a 96-well plate 24 h prior to incubation with the corresponding nanoparticle doses 
and allowed to adhere. For differentiating THP1 monocytes into macrophages, THP-1 monocytes 
were seeded at a density of 70,000 cells/well in 96-well plates and differentiated with phorbol 12-
myristate 13-acetate (PMA) for 3 days.  
Nanoparticles were added to the cells in complete growth medium at different concentrations 
(0.0125-0.4 mg/mL) and, then, cells were maintained in the standard culture conditions for 24 h. 
After incubation, cells were washed with Dulbecco's Phosphate Buffered Saline (DPBS, Biowest) 
and incubated with complete growth medium containing 10% (v/v) Alamar Blue reagent for 4 h. 
The fluorescence intensity of the medium was measured in a multi-mode Synergy HT Microplate 
Reader at excitation and emission wavelengths of 530 nm and 590 nm, respectively (Biotek). The 
potential nanoparticle interference with the method was evaluated and discarded. Cell viability 
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was expressed as a relative percentage to the untreated control cells value. The percentages 
obtained depict the average of five values. The morphology of macrophages after internalizing 
upconversion nanoparticles was evaluated by SEM. Cells were cultured in gelatinized glass and 
fixed in paraformaldehyde 4% in PBS (Affymetrix, UK) for 30 minutes. Then, samples were 
washed with PBS, dried and coated with a thin Pt layer. Images were recorded in an Inspect™ 
F50 SEM (FEI Company) in an energy range between 10-15 keV. 
In order to verify the oxidative cell damage mediated by ROS generated by NIR irradiation, 
B16F1, human dermal fibroblasts, mMSCs and human macrophages were seeded on 24-well 
plates at cell densities of 40000, 45000, 50000 and 500000 cells/well, respectively. Then, PLGA-
PEG NPs containing upconversion nanoparticles and Protoporphyrin IX (0.4 mg/mL) were added 
to the cells. After incubation for 24h, cells were irradiated with a NIR laser (808 nm; 5, 10 and 20 
min at 5.2 W/cm2). Changes in cell well temperature were also monitored to discard any thermal 
mediated dead. Then, cell damage was evaluated by fluorescence microscopy just after irradiation 
and after 24h by using the LIVE/DEAD Viability/Cytotoxicity Kit (Thermo-Fisher Scientific, 
USA) following the manufacturer instructions. Briefly, a solution containing 2 μM calcein AM 
and 4 μM ethidium homodimer-1 was added to the cells and incubated at room temperature for 30 
min. Samples were evaluated in an inverted fluorescence microscope Olympus IX81 through the 
composition of 20 fields on each well acquired at 4X magnification to obtain a mosaic of the 
central area of each well. Control samples (not treated and/or irradiated) were also assayed in 
order to check the basal status of cells. Furthermore, samples treated with the separated NP 
components (i.e., just protoporphyrin, just upconversion nanoparticles or just PLGA-PEG) and 
irradiated were also run to verify the restricted effect of ROS damage mediated by NIR irradiation 
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after treatment with the final product. These separated materials were added at the same 
concentration present in the final NPs. 
ROS generation using a red-ox sensitive probe. ROS generation was indirectly evaluated by 
using Dihydrorhodamine 123 (DHR123) conversion to its oxidized and cationic form (i.e., 
rhodamine 123) under the presence of ROS. DHR123 is nonfluorescent but its oxidized derivative 
(R123) emits strong green fluorescence at 530 nm42. A nanoparticulated dispersion of the 
pegylated upconversion nanoparticles at 5 mg/mL was mixed with 50 μL of 330 μM DHR123 in 1 
mL of ethanol. The final dispersion was irradiated at 11 W/cm2 (at 980 nm) to evaluate the 
amount of ROS generated. The generation of R123 was monitored by using fluorescence 
spectroscopy using excitation and emission wavelengths of 485 nm and 530 nm, respectively. As 
control, the influence of the light and heating caused by the irradiation were also evaluated in 
order to discriminate the ROS generation attributed exclusively to the nanoparticles. Sample 
fluorescence was quantified before and after 2 hours of irradiation or heating. 
Singlet oxygen generation detection. Singlet oxygen sensor green (SOSG, Molecular Probes, 
Eugene, OR, USA) (100 µg) was dissolved in 33 µL of methanol. The solution was then diluted 
with water by a factor of 100. The final SOSG solution was added to 9 mg/mL of nanoparticle 
dispersion in a 1:4 volume ratio. Irradiation was performed using a laser source at 808 nm, 15 
min, 800 mW/cm2. The fluorescence of oxidized SOSG was detected using an excitation 
wavelength of 504 nm and an emission wavelength of 525 nm.  
Ex vivo skin permeation experiment. Human skin was collected according to the ethical 
guidelines of the Institutional Review Board at Boston Children’s Hospital and was used to assess 
the ex vivo skin penetration depth of nanoparticles during topical drug administration. Human skin 
with a proper size was sandwiched between the donor and acceptor chamber of the Franz 
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Diffusion Cell (Inner diameter: 5 mm, area: 0.262 cm2; volume: 5 mL). The stratum corneum side 
of the skin was put upward touching the donor chamber.  Then, 0.2 mL of each sample (saline, 
free PPIX at 0.0125 mg/mL or PPIX-loaded nanoparticles) were added into the donor chamber, 
while 5mL of phosphate buffer (pH 7.4) was filled into the receptor chamber. The temperature of 
the compartments was maintained at 37 ℃ using a circulating water bath under gentle stirring with 
magnetic stirrers. After a 24 h incubation period, the skin samples were taken out from the Franz 
cells and were embedded in O.C.T. Compound (Tissue-Tek) and rapidly cooled with dry ice. 
Afterward, sections were sliced with a Cryostat Leica CM3050S (slide thickness: 10μm). The skin 
permeation of each of the treatment groups was then observed using Zeiss LSM 710 Multiphoton 
Laser Scanning Confocal Microscope. DAPI was used to stain nuclei acid of the tissues. 
Statistical analysis. Results are expressed as the mean ± SD. Statistical study of data was 
performed by using the StataSE 12 statistical software (StataCorp LP, USA). Normal distribution 
of the variables was analyzed by the Shapiro-Wilk test followed by the U-Mann-Whitney or 
Student test. Statistically significant differences among groups were considered when p ≤ 0.05. 
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